https://www.bloomberg.com/authors/ATcocXTXJcE/jeannie-baumannhttps://www.bloomberg.com/feeds/static/images/bloomberg_logo_black.pnghttps://www.bloomberg.com/authors/ATcocXTXJcE/jeannie-baumannRSS for NodeSun, 19 Apr 2026 19:32:02 GMThttps://www.bloomberg.com/news/articles/2025-02-16/us-health-department-layoffs-expand-to-medicare-fdahttps://www.bloomberg.com/news/articles/2025-02-16/us-health-department-layoffs-expand-to-medicare-fdaSun, 16 Feb 2025 17:03:32 GMThttps://www.bloomberg.com/news/articles/2023-11-16/fda-deputy-commissioner-janet-woodcock-to-retire-next-yearhttps://www.bloomberg.com/news/articles/2023-11-16/fda-deputy-commissioner-janet-woodcock-to-retire-next-yearThu, 16 Nov 2023 19:31:00 GMTJanet Woodcockhttps://www.bloomberg.com/news/articles/2023-08-02/nih-taps-marrazzo-as-successor-to-anthony-fauci-at-us-infectious-disease-agencyhttps://www.bloomberg.com/news/articles/2023-08-02/nih-taps-marrazzo-as-successor-to-anthony-fauci-at-us-infectious-disease-agencyWed, 02 Aug 2023 14:26:58 GMTDr. Jeanne Marrazzohttps://www.bloomberg.com/news/articles/2023-06-16/biden-to-formally-tap-mandy-cohen-for-cdc-director-imminentlyhttps://www.bloomberg.com/news/articles/2023-06-16/biden-to-formally-tap-mandy-cohen-for-cdc-director-imminentlyFri, 16 Jun 2023 15:45:59 GMTWASHINGTON, DC - NOVEMBER 03: Dr. Mandy Cohen, COO and chief of staff of the Centers for Medicare and Medicaid, attends aÊHouse Ways and Means Committee hearing on Capitol Hill November 3, 2015 in Washington, DC. The committee was hearing testimony on the State of The Affordable Care Act's Consumer Operated and Oriented Plan (CO-OP) Program. (Photo by Mark Wilson/Getty Images)https://www.bloomberg.com/news/articles/2023-02-15/fda-advisers-to-consider-emergent-s-ebs-narcan-spray-as-otc-overdose-antidotehttps://www.bloomberg.com/news/articles/2023-02-15/fda-advisers-to-consider-emergent-s-ebs-narcan-spray-as-otc-overdose-antidoteWed, 15 Feb 2023 12:00:00 GMThttps://www.bloomberg.com/news/articles/2023-01-13/biden-covid-19-adviser-kessler-to-depart-as-pandemic-waneshttps://www.bloomberg.com/news/articles/2023-01-13/biden-covid-19-adviser-kessler-to-depart-as-pandemic-wanesFri, 13 Jan 2023 19:30:00 GMTJoe Biden attends a coronavirus briefing at The Queen theater in Wilmington, Oct. 28, 2020.https://www.bloomberg.com/news/articles/2022-12-21/us-releases-tamiflu-reserves-amid-rising-flu-season-demandhttps://www.bloomberg.com/news/articles/2022-12-21/us-releases-tamiflu-reserves-amid-rising-flu-season-demandWed, 21 Dec 2022 18:45:24 GMThttps://www.bloomberg.com/news/articles/2022-12-05/flu-rates-surge-around-us-as-white-children-s-shots-laghttps://www.bloomberg.com/news/articles/2022-12-05/flu-rates-surge-around-us-as-white-children-s-shots-lagMon, 05 Dec 2022 18:32:49 GMThttps://www.bloomberg.com/news/articles/2022-11-04/rapid-start-to-annual-flu-lung-virus-season-poses-threat-to-hospitalshttps://www.bloomberg.com/news/articles/2022-11-04/rapid-start-to-annual-flu-lung-virus-season-poses-threat-to-hospitalsFri, 04 Nov 2022 16:18:07 GMTOrange, CA - November 01: A nasopharyngeal sample collection kit that tests for RSV, COVID-19, influenza A and B, shown here at Providence St. Joseph Hospital in Orange on Tuesday, November 1, 2022. Orange Countys health officer has declared a local health emergency in response to increases in respiratory illnesses and an onslaught of the quickly spreading RSV, a respiratory virus that is most dangerous in young children. (Photo by Mark Rightmire/MediaNews Group/Orange County Register via Getty Images)https://www.bloomberg.com/news/articles/2022-10-27/covid-lab-leak-theory-gets-boost-from-senate-republican-reporthttps://www.bloomberg.com/news/articles/2022-10-27/covid-lab-leak-theory-gets-boost-from-senate-republican-reportThu, 27 Oct 2022 17:02:06 GMThttps://www.bloomberg.com/news/articles/2022-10-19/low-income-kids-should-get-free-covid-shots-cdc-panel-sayshttps://www.bloomberg.com/news/articles/2022-10-19/low-income-kids-should-get-free-covid-shots-cdc-panel-saysWed, 19 Oct 2022 20:03:02 GMTA healthcare worker fills a low-dead space syringe with the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in Vancouver, British Columbia, Canada, on Thursday, March 4, 2021. Low-dead space syringes are designed to minimize the "dead space" between the plunger and needle, making them a crucial tool in extracting six doses, instead of the five that were expected, from each Pfizer vial.https://www.bloomberg.com/news/articles/2022-10-17/trump-s-cdc-changed-weekly-reports-house-covid-panel-findshttps://www.bloomberg.com/news/articles/2022-10-17/trump-s-cdc-changed-weekly-reports-house-covid-panel-findsMon, 17 Oct 2022 17:02:13 GMTDonald Trump Photographer: Chris Kleponis/Polaris/Bloomberghttps://www.bloomberg.com/news/articles/2022-10-07/covid-fall-boosters-could-save-thousands-of-lives-hhs-officials-sayhttps://www.bloomberg.com/news/articles/2022-10-07/covid-fall-boosters-could-save-thousands-of-lives-hhs-officials-sayFri, 07 Oct 2022 16:30:00 GMTA healthcare worker administers a third dose of the Pfizer-BioNTech Covid-19 vaccine at a senior living facility in Worcester, Pennsylvania, U.S., on Wednesday, Aug. 25, 2021. Pfizer Inc. and BioNTech SE are seeking full U.S. approval for a Covid-19 booster shot for people 16 and older, asking regulators to sign off on a third dose to quell a rise in infections among vaccinated people.https://www.bloomberg.com/news/articles/2022-09-28/with-monkeypox-outbreak-slowing-focus-shifts-to-preventionhttps://www.bloomberg.com/news/articles/2022-09-28/with-monkeypox-outbreak-slowing-focus-shifts-to-preventionWed, 28 Sep 2022 18:48:02 GMTA health worker handles a vial of the Bavarian Nordic A/S Jynneos monkeypox vaccine at the Calit Medical Center in Tel Aviv, Israel on Sunday, July 31, 2022. As health authorities all over the globe search for ways to stop the monkeypox outbreak, investors are snapping up shares of companies that could benefit from the race to quell the disease.https://www.bloomberg.com/news/articles/2022-09-09/siga-s-tpoxx-looks-safe-for-monkeypox-patients-in-early-analysishttps://www.bloomberg.com/news/articles/2022-09-09/siga-s-tpoxx-looks-safe-for-monkeypox-patients-in-early-analysisFri, 09 Sep 2022 18:45:37 GMTSIGA Technologies Tpoxx antiviral medication Photographer: Elijah Nouvelage/Bloomberghttps://www.bloomberg.com/news/articles/2022-09-06/covid-likely-to-require-yearly-booster-like-flu-shot-fauci-sayshttps://www.bloomberg.com/news/articles/2022-09-06/covid-likely-to-require-yearly-booster-like-flu-shot-fauci-saysTue, 06 Sep 2022 16:19:46 GMThttps://www.bloomberg.com/news/articles/2022-08-31/fauci-warns-of-a-bad-flu-season-brewing-as-he-nears-office-exithttps://www.bloomberg.com/news/articles/2022-08-31/fauci-warns-of-a-bad-flu-season-brewing-as-he-nears-office-exitWed, 31 Aug 2022 18:43:36 GMThttps://www.bloomberg.com/news/articles/2022-08-30/monkeypox-us-shifting-aid-to-target-lgbtq-racial-minoritieshttps://www.bloomberg.com/news/articles/2022-08-30/monkeypox-us-shifting-aid-to-target-lgbtq-racial-minoritiesTue, 30 Aug 2022 20:10:38 GMTVials of the Bavarian Nordic A/S Jynneos monkeypox vaccine at the Calit Medical Center in Tel Aviv, Israel on Sunday, July 31, 2022. As health authorities all over the globe search for ways to stop the monkeypox outbreak, investors are snapping up shares of companies that could benefit from the race to quell the disease.https://www.bloomberg.com/news/articles/2022-08-25/fauci-expected-covid-to-be-behind-us-a-year-into-biden-s-termhttps://www.bloomberg.com/news/articles/2022-08-25/fauci-expected-covid-to-be-behind-us-a-year-into-biden-s-termThu, 25 Aug 2022 14:58:03 GMThttps://www.bloomberg.com/news/articles/2022-08-24/monkeypox-response-senate-committee-plans-hearings-with-quiz-health-officialshttps://www.bloomberg.com/news/articles/2022-08-24/monkeypox-response-senate-committee-plans-hearings-with-quiz-health-officialsWed, 24 Aug 2022 19:55:56 GMTA health worker handles a vial of the Bavarian Nordic A/S Jynneos monkeypox vaccine at the Calit Medical Center in Tel Aviv, Israel on Sunday, July 31, 2022. As health authorities all over the globe search for ways to stop the monkeypox outbreak, investors are snapping up shares of companies that could benefit from the race to quell the disease. Photographer: Kobi Wolf/Bloomberg